ABOUT ACTIGRAPH
ActiGraph is pioneering the digital transformation of clinical research. We provide end-to-end digital health technology (DHT) solutions by integrating and operationalizing the best hardware, software, and algorithms to generate reliable evidence and get the right treatments to the right patients, faster. ActiGraph’s medical-grade wearable technology platform has been used to capture real-world, continuous digital measures for nearly 200 industry-sponsored clinical trials and thousands of academic research studies. Appearing in over 20,000 published scientific papers to date, ActiGraph is the most experienced and trusted wearable technology partner in the industry.
DIGITAL ENDPOINTS LIBRARY
-
![GettyImages-1352619772 running]( "Digital Endpoints Of Gait And Balance In The Real World")
Discover how recent advancements in wearable sensors and data science have provided the opportunities for objective and unobtrusive assessment of walking in the real world.
-
![GettyImages-1304430076 oncology ps]( "Guide To Digital Endpoints In Oncology Research")
People with cancer emphasize quality of life (QOL) as an important health outcome across their journey. Explore how digital health technologies can collect patient-centric outcomes passively and remotely, minimizing the burden for people to participate in clinical trials.
-
![Human Heart with Blood Vessels-iStock-1339646493]( "Heart Failure Indication Guide")
Heart failure patients suffer a range of symptoms that negatively affect their quality of life. Learn how digital health technologies present an opportunity to track patient-centric outcomes.
-
![iStock-1182475990-scratching]( "Objective Scratch Assessments Using Digital Health Technologies (DHTs)")
This white paper explores how an objective scratch measure is now achievable through the use of wrist-worn wearable technology that is both non-invasive and easy to implement.
-
![Wearable iStock-1257436276]( "A Guide To Wearable-Enabled Digital Clinical Measures In Neuroscience")
Drug development in neurology is notoriously challenging. Despite being one of the most active areas of clinical development, neurological disease drug trials have among the longest development timelines and highest failure rates in the industry. Learn more in the available e-Book.
-
![wearable sensor sleeping iStock-1172175348]( "Actigraphy For Sleep Measurement")
Wearable devices provide a low-burden and remote approach to objectively quantify people’s sleep in their real life, often revealing meaningful insights that might not be available with polysomnography or self report data. While sleep architecture and sleep staging are difficult to estimate with accelerometry alone, actigraphy is sensitive to treatment effects in previous studies of sleep disorders.
CONTACT INFORMATION
ActiGraph
70 N Baylen St, Suite 400
Pensacola, FL 32502
UNITED STATES
Phone: 850.332.7900
Contact: Genevieve Baley
FEATURED ARTICLES
- Real-World Sleep Assessments Using Wearable Technologies
- First Pivotal Trial With Data From Wearables As FDA-Endorsed Primary Endpoint
- Accelerate Clinical Development With Patient-Centered Digital Endpoints
- Guide To Digital Endpoints In Rheumatology Research
- Digital Endpoints Of Gait And Balance In The Real World
- Guide To Digital Endpoints In Oncology Research
- Heart Failure Indication Guide
- Maximize Your R&D Investment In DHTs Through The Use Of Raw Sensor Data
- Generating A Novel Measure Of Scratch Using Wrist-Worn Wearables
- Understanding The New FDA DHT Guidance
- How To Optimize Adherence Of Wearables In Your Clinical Research
- Objective Scratch Assessments Using Digital Health Technologies (DHTs)
- Understanding Usability: Guidance For Gathering Complete, Unbiased Data From Wearables
- How Actigraphy Is Clearing Operational Barriers To Decentralized Trials
- Measuring Sleep With Actigraphy: Three Use Cases
- Reimagining Oncology Clinical Trials With Digital Biomarkers
- Actigraphy For Sleep Measurement
- Paving The Way For Virtual Trials In Neurology: A Fully Remote ALS Study
- Why Is Oncology Drug Development Late To The Digital Biomarkers Game?
- Bridging The Knowledge Gap On Digital Clinical Measures: A Technology Partner’s Perspective On The ‘The Playbook’
WEBINARS
-
![digital health technologies webinar]( "Operationalizing Digital Health Technologies: Successes And Failures In Clinical Research")
In this webinar, clinical operations leaders discuss the inherent challenges of deploying and managing DHTs and best practices to fully realize their value in clinical investigation.
-
![What The New FDA Guidance On Electronic Records And Signatures Means For Clinical Trials]( "Exploring The Role Of Wearable Biosensors Within The DCT Ecosystem")
In this pre-recorded webinar, experts from the industry share real-world insights and practical guidance on how to achieve success in decentralized clinical trials.
-
![iStock-1214112149-scientistis-lab-team-discovery]( "How Can Better Alignment Between Academia And Industry Accelerate The Discovery And Validation Of Digital Endpoints?")
During this panel discussion, key opinion leaders from biopharma and academia explore ways to bridge the knowledge gap that exists between these groups and foster research collaborations to help advance the use of digital endpoints in clinical development.
-
![iStock-1256323051-scientist-research-lab-development-samples-microscope]( "How Wearable Devices And Digital Clinical Measures Can Improve Neurology Trials")
Drug development in neurology is notoriously challenging. Despite being one of the most active areas of clinical development, neurological disease drug trials have among the longest development timelines and highest failure rates in the industry. In this webinar, learn how digital clinical measures enabled by wearables have great potential to transform and accelerate drug development in neuroscience.
-
![Wearables Whitepaper Image]( "Oncology Research And Care: Reimagining Digital Innovation")
During this webinar, speakers will discuss how they are successfully deploying wearable and remote monitoring technologies to improve clinical outcomes in patients living with cancer.
-
![ActiGraph]( "Navigating The Journey Towards \"Future-Proof\" Clinical Data Assets")
During this educational webinar hosted by Xtalks, data experts from ActiGraph and Koneksa Health present a roadmap to help clinical trial sponsors and their partners design and implement a “future-proof” raw data strategy to maximize the long-term value of digital biomarker data.
-
![ActiGraph3]( "What Level Of Evidence Is Needed To Evaluate Biomarkers And Measurements?")
During this virtual presentation from the 2020 Digital Biomarkers & Digital Measurements Summit, industry thought leaders from ActiGraph, Atlantic Council, Elektra Labs, and NeuroLogica answer key questions around the evaluation and evidence required to select digital clinical measures.
-
![ActiGraph]( "Wearable Data Gone Awry: Cautionary Tales From The Clinical Research Trenches")
During this fireside chat, data experts from ActiGraph, VivoSense, and Elektra Labs share cautionary tales of data collection gone awry and how the teams found creative solutions for the problems at hand. Panelists recount real life examples of data collection efforts that missed the mark and provide strategies, tools, and guidance to help clinical teams avoid common missteps in the first place.
-
![ActiGraph2]( "Developing An Effective Data Asset Strategy For Wearables")
A panel of wearable technology experts from ActiGraph, Takeda, Bristol Myers Squibb, Roche, and the University of California, San Diego explore analytical and clinical validation of wearable technologies, the future of algorithms used in academic and clinical research, and more during this on-demand Spotlight Session from the 2020 CNS Summit.
